Objective: Pseudotumor cerebri syndrome (PTCS) is characterized by symptoms and signs of increased intracranial pressure without ventriculomegaly, intracranial tumor or mass. This study aimed to explore and analyze 34 pa...
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...
With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks....
Ahmet Özşimşek (2018). Choreiform Movement Disorder Associated with Subdural Hematoma: A Case Report. UNKNOWN, 24(1),
94-95. https://europub.co.uk./articles/-A-277590
Sign In Europub
For faster login or register use your social account.
Clinical and Demographic Features of Pseudotumor Cerebri Syndrome Diagnosed in a University Hospital
Objective: Pseudotumor cerebri syndrome (PTCS) is characterized by symptoms and signs of increased intracranial pressure without ventriculomegaly, intracranial tumor or mass. This study aimed to explore and analyze 34 pa...
Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!
.
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks....
A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
.